NDC 58829-303 - Furosemide 1%
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 58829-303
- Package NDCs from labels
- 58829-303-60
- Manufacturer
- FIRST PRIORITY INCORPORATED
- Effective date
- 2023-11-02
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Furosemide 1% - FIRST PRIORITY INCORPORATED | FIRST PRIORITY INCORPORATED | 2023-11-02 | PRESCRIPTION ANIMAL DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 58829-303-60 | Furosemide1% | 12 in 1 CASE | SYRUP | 12 | 6 | |
| 58829-303-60 | Furosemide1% | 1 in 1 CARTON | SYRUP | 1 | 6 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| FUROSEMIDE | ACTIVE INGREDIENT | 7LXU5N7ZO5 | FUROSEMIDE 1% (FUROSEMIDE) SYRUP [FIRST PRIORITY INCORPORATED] | 3 | |
| FUROSEMIDE | ACTIVE MOIETY | 7LXU5N7ZO5 | FUROSEMIDE 1% (FUROSEMIDE) SYRUP [FIRST PRIORITY INCORPORATED] | 3 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| FUROSEMIDE | FUROSEMIDE | Hospira, Inc. | aaced7a8-c3d7-4d66-8c07-aa407b8b3f35 | 2026-05-13 | Warnings, Adverse reactions | 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | Cardinal Health 107, LLC | 8e0bac29-5a8b-4d4e-93b3-2e21eb3b0650 | 2026-05-06 | Warnings, Adverse reactions | 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | Preferred Pharmaceuticals, Inc. | a23fc1e0-2d16-43a8-a34e-f6505dcd6316 | 2026-04-29 | Warnings, Adverse reactions | 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | Preferred Pharmaceuticals Inc. | cad102d7-0197-4cff-bb80-9f0b5bcb599b | 2026-04-29 | Warnings, Adverse reactions | 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | REMEDYREPACK INC. | 7181e528-c862-4dd7-8446-9011e4c7312a | 2026-04-23 | Warnings, Adverse reactions | 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | Redpharm Drug | 37457273-38a1-f938-e063-6294a90a50ab | 2026-04-15 | Warnings, Adverse reactions | 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 1b9117d5-0dd9-4577-a1fd-bb0aaf7e68ec | 2026-03-18 | Boxed warning, Warnings, Adverse reactions | 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | Coupler LLC | 4cc2c2d1-2fa4-f6b6-e063-6294a90a290e | 2026-03-11 | Warnings, Adverse reactions | 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | Direct_Rx | e9be5c3b-4b18-7ad2-e053-2995a90a4a8b | 2026-03-09 | Warnings, Adverse reactions | 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | Marlex Pharmaceuticals, Inc. | 4bd1b15e-354e-051f-e063-6294a90a3f3b | 2026-03-01 | Warnings, Adverse reactions | 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | NuCare Pharmaceuticals,Inc. | bd45c963-a413-e9a1-e053-2a95a90a1438 | 2026-02-19 | Warnings, Adverse reactions | 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | Preferred Pharmaceuticals Inc. | adda78ee-0cf5-4613-a748-5d6571afe354 | 2026-01-19 | Warnings, Adverse reactions | 7LXU5N7ZO5 |
| FUROSEMIDE | FUROSEMIDE | Cardinal Health 107, LLC | 2590ebb6-ce2a-4e23-9244-e54e3010d488 | 2026-01-15 | Boxed warning, Warnings, Adverse reactions | 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | AvKARE | d4c532be-1f3f-60d3-e053-2995a90a98be | 2026-01-14 | Warnings, Adverse reactions | 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | Meitheal Pharmaceuticals Inc. | a2e3c748-28ce-4c50-a182-721912919840 | 2026-01-14 | Warnings, Adverse reactions | 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | A-S Medication Solutions | 8f56d6f6-a5ea-4171-9e24-d2fdb11a65f8 | 2026-01-13 | Warnings, Adverse reactions | 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | Micro Labs Limited | 2f547f7c-0322-465c-9764-43f955d98ab2 | 2026-01-11 | Boxed warning, Warnings, Adverse reactions | 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | Phlow Corporation | 08a44bdd-028d-41af-9d4e-70971b0bcc4e | 2026-01-09 | Warnings, Adverse reactions | 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | Northwind Health Company, LLC | 13ba97a7-598a-76a4-e063-6294a90a45c5 | 2026-01-02 | Warnings, Adverse reactions | 7LXU5N7ZO5 |
| FUROSEMIDE | FUROSEMIDE | Northwind Health Company, LLC | 1d99e151-75ba-6a75-e063-6294a90a4360 | 2026-01-01 | Warnings, Adverse reactions | 7LXU5N7ZO5 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.